{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:41:57Z","timestamp":1759452117467,"version":"build-2065373602"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"}],"funder":[{"DOI":"10.13039\/501100006254","name":"Ruhr-Universit\u00e4t Bochum","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006254","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00105-025-05545-6","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T16:24:14Z","timestamp":1752510254000},"page":"654-656","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Histologische und klinische \u00dcberschneidung von Acne inversa und Morbus Crohn unter IL-17-Inhibition","Histological and clinical overlap of hidradenitis suppurativa and Crohn disease under IL-17 inhibition"],"prefix":"10.1007","volume":"76","author":[{"given":"Lennart","family":"Ocker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Scheel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nessr","family":"Abu Rached","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"D\u00f6rler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"St\u00fccker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Falk","family":"Bechara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"key":"5545_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1369\/0022155420978535","volume":"69","author":"SR Altman","year":"2021","unstructured":"Altman\u00a0SR, Criswell\u00a0SL (2021) Dynamic Leukocyte Populations Are Associated With Early- and Late-stage Lesions in Hidradenitis Suppurativa. J\u00a0Histochem Cytochem 69:191\u2013201. https:\/\/doi.org\/10.1369\/0022155420978535","journal-title":"J Histochem Cytochem"},{"key":"5545_CR2","doi-asserted-by":"publisher","first-page":"105782","DOI":"10.1016\/j.humpath.2025.105782","volume":"158","author":"T Chen","year":"2025","unstructured":"Chen\u00a0T, Birkness-Gartman\u00a0JE, Larman\u00a0TC (2025) Emerging manifestations of IL-17 immunomodulation in the gastrointestinal tract. Hum Pathol 158:105782. https:\/\/doi.org\/10.1016\/j.humpath.2025.105782","journal-title":"Hum Pathol"},{"key":"5545_CR3","doi-asserted-by":"publisher","first-page":"1124628","DOI":"10.3389\/fphar.2023.1124628","volume":"14","author":"Z Deng","year":"2023","unstructured":"Deng\u00a0Z, Wang\u00a0S, Wu\u00a0C, Wang\u00a0C (2023) IL-17 inhibitor-associated inflammatory bowel disease: A\u00a0study based on literature and database analysis. Front Pharmacol 14:1124628. https:\/\/doi.org\/10.3389\/fphar.2023.1124628","journal-title":"Front Pharmacol"},{"key":"5545_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/cei.13449","volume":"201","author":"JM Fletcher","year":"2020","unstructured":"Fletcher\u00a0JM, Moran\u00a0B, Petrasca\u00a0A, Smith\u00a0CM (2020) IL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa. Clin Exp Immunol 201:121\u2013134. https:\/\/doi.org\/10.1111\/cei.13449","journal-title":"Clin Exp Immunol"},{"key":"5545_CR5","doi-asserted-by":"publisher","first-page":"90277","DOI":"10.1016\/s0190-9622","volume":"96","author":"GB Jemec","year":"1996","unstructured":"Jemec\u00a0GB, Hansen\u00a0U (1996) Histology of hidradenitis suppurativa. J\u00a0Am Acad Dermatol 96:90277\u201390277. https:\/\/doi.org\/10.1016\/s0190-9622","journal-title":"J Am Acad Dermatol"},{"key":"5545_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/cpt.2155","volume":"110","author":"N Petitpain","year":"2021","unstructured":"Petitpain\u00a0N, D\u2019Amico\u00a0F, Yelehe-Okouma\u00a0M, Jouzeau\u00a0J\u2011Y, Netter\u00a0P, Peyrin-Biroulet\u00a0L, Gillet\u00a0P (2021) IL-17 Inhibitors and Inflammatory Bowel Diseases: A\u00a0Postmarketing Study in Vigibase. Clin Pharmacol Ther 110:159\u2013168. https:\/\/doi.org\/10.1002\/cpt.2155","journal-title":"Clin Pharmacol Ther"},{"key":"5545_CR7","doi-asserted-by":"publisher","first-page":"4802","DOI":"10.3748\/wjg.v22.i20.4802","volume":"22","author":"M Principi","year":"2016","unstructured":"Principi\u00a0M, Cassano\u00a0N, Contaldo\u00a0A, Iannone\u00a0A, Losurdo\u00a0G, Barone\u00a0M, Mastrolonardo\u00a0M, Vena\u00a0GA, Ierardi\u00a0E, Di Leo\u00a0A (2016) Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing association. World J Gastroenterol 22:4802\u20134811. https:\/\/doi.org\/10.3748\/wjg.v22.i20.4802","journal-title":"World J Gastroenterol"},{"key":"5545_CR8","doi-asserted-by":"publisher","first-page":"622934","DOI":"10.3389\/fimmu.2021.622934","volume":"12","author":"H Schmitt","year":"2021","unstructured":"Schmitt\u00a0H, Neurath\u00a0MF, Atreya\u00a0R (2021) Role of the IL23\/IL17 Pathway in Crohn\u2019s Disease. Front Immunol 12:622934. https:\/\/doi.org\/10.3389\/fimmu.2021.622934","journal-title":"Front Immunol"},{"key":"5545_CR9","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1136\/gut.32.12.1514","volume":"32","author":"CA Seldenrijk","year":"1991","unstructured":"Seldenrijk\u00a0CA, Morson\u00a0BC, Meuwissen\u00a0SG, Schipper\u00a0NW, Lindeman\u00a0J, Meijer\u00a0CJ (1991) Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease: diagnostic implications. Gut 32:1514\u20131520. https:\/\/doi.org\/10.1136\/gut.32.12.1514","journal-title":"Gut"},{"key":"5545_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3390\/dermatopathology9030029","volume":"9","author":"SDB Smith","year":"2022","unstructured":"Smith\u00a0SDB, Okoye\u00a0GA, Sokumbi\u00a0O (2022) Histopathology of Hidradenitis Suppurativa: A\u00a0Systematic Review. Dermatopathology 9:251\u2013257. https:\/\/doi.org\/10.3390\/dermatopathology9030029","journal-title":"Dermatopathology"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-025-05545-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-025-05545-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-025-05545-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:16:23Z","timestamp":1759410983000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-025-05545-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["5545"],"URL":"https:\/\/doi.org\/10.1007\/s00105-025-05545-6","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"type":"print","value":"2731-7005"},{"type":"electronic","value":"2731-7013"}],"subject":[],"published":{"date-parts":[[2025,7,14]]},"assertion":[{"value":"24 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"L.\u00a0Ocker erhielt Referentenhonorare und Reisekostenunterst\u00fctzung von Novartis Pharma GmbH, UCB Pharma GmbH, Johnson-Johnson und Incyte Corporation. N.\u00a0Abu Rached erhielt Referentenhonorare und Reisekostenunterst\u00fctzung von Novartis Pharma GmbH. F.\u00a0Bechara erhielt Honorare f\u00fcr die Teilnahme an Advisory Boards, klinischen Studien und\/oder als Referent von AbbVie Inc., Novartis Pharma GmbH, UCB Pharma, Incyte Corporation, Janssen-Cilag GmbH und MoonLake. C.\u00a0Scheel, M.\u00a0D\u00f6rler und M.\u00a0St\u00fccker geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}